Laboratory Of America Holdings Boosts Testing Services with Strategic Leadership Appointment at Millstone
- Michael Quin appointed Senior Director of Laboratory Services to enhance Millstone Medical's testing capabilities for OEMs.
- Quin's 25+ years of experience in medical devices and pharmaceuticals will improve compliance with evolving regulations.
- Millstone's expanded testing capacity and strategic focus aim to set industry standards for quality and patient safety.
Strategic Leadership Appointment Enhances Laboratory Services at Millstone Medical Outsourcing
Millstone Medical Outsourcing strengthens its laboratory services by appointing Michael Quin as Senior Director of Laboratory Services for Millstone Medical Testing. This strategic decision aims to bolster the company's testing capabilities for global medical device original equipment manufacturers (OEMs) amidst a complex regulatory landscape. Following the inauguration of a new 25,000-square-foot ISO 17025-certified testing facility last year, which has already improved laboratory capacity and reduced lead times, Quin's extensive experience in the medical device and pharmaceutical industries positions him to significantly enhance service delivery.
Quin brings over 25 years of expertise, having held pivotal roles at renowned companies such as Johnson & Johnson's DePuy, USCI Bard, and Amgen. His background in microbiology, sterility assurance, and contamination control is particularly relevant as Millstone navigates the increasing scrutiny imposed by FDA Quality Management System Regulation (QMSR) and EU Medical Device Regulation (MDR). CEO Karl Neuberger expresses confidence in Quin’s ability to elevate testing services, recognizing the mounting demand for rapid compliance among OEMs due to evolving regulatory requirements.
Highlighting Millstone's commitment to quality and testing, Quin notes that the company's integrated model encompasses essential services such as packaging, testing, and logistics. His focus on enhancing sterility assurance systems and expanding testing services is crucial for product development and patient safety. By providing OEMs with efficient, compliant, and integrated solutions, Quin aims to mitigate risks and accelerate time to market. Millstone's ongoing investments in testing capabilities position it to set industry standards for quality and responsiveness, ultimately ensuring that it remains competitive in a rapidly evolving regulatory environment.
In addition to the leadership appointment, Millstone's recent expansion of its testing capacity underscores its strategic vision to meet the demands of the medical device industry. With Quin at the helm, the company is well-positioned to enhance its offerings and support clients in navigating stringent regulatory frameworks. The emphasis on rapid compliance and quality assurance reflects a broader trend within the industry as companies prioritize patient safety and product efficacy in their operations.
The commitment to enhancing testing services not only addresses current market needs but also sets a precedent for industry standards in quality and responsiveness. Millstone Medical Outsourcing is poised to lead the way in providing comprehensive solutions that meet the rigorous demands of today's healthcare landscape.
